Generic Dacogen by RDY is not a big deal for the future of ASTX. Good companies are not just a one hit wonder. That is why ASTX has a number of drugs in its pipeline and a significant improvement on the way to replace Dacogen. Shorts try to make a big deal on old news. Timing on the replacement by RDY may be a surprise but not a big deal for the future of a leader like ASTX. Remember RDY did not invent Dacogen they simply copied it. I like companies like ASTX that invent, develop, and create break through technology. ASTX is one of the few companies of their size that does not have debt on the books. Even RDY has debt on their books. I have no plans on sell my ASTX until it breaks through $10 and then I will revaluate. Shorts can yell and scream about small problems/issues all they want, but I am in ASTX for the long run.